73
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells

, , , , , & show all
Pages 2945-2954 | Published online: 18 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Leisheng Wang, He En, Lei Yang, Yanbing Zhang, Baisheng Sun & Jianjiang Gao. (2019) miR-596 suppresses the expression of Survivin and enhances the sensitivity of osteosarcoma cells to the molecular targeting agent anlotinib. OncoTargets and Therapy 12, pages 6825-6838.
Read now
Xudong Gao, Hebing Chen, Xin Huang, Hao Li, Zhen Liu & Xiaochen Bo. (2019) ARQ-197 enhances the antitumor effect of sorafenib in hepatocellular carcinoma cells via decelerating its intracellular clearance. OncoTargets and Therapy 12, pages 1629-1640.
Read now
Yan Wang, Meng Zhao, Huishan Zhao, Shi Cheng, Rixing Bai & Maomin Song. (2019) MicroRNA-940 restricts the expression of metastasis-associated gene MACC1 and enhances the antitumor effect of Anlotinib on colorectal cancer. OncoTargets and Therapy 12, pages 2809-2822.
Read now
Xiao Li, Wei Wang, Yi Fan, Yue Wei, Li-Qin Yu, Ji-Fu Wei & Yi-Fen Wang. (2018) Anticancer efficiency of cycloartane triterpenoid derivatives isolated from Cimicifuga yunnanensis Hsiao on triple-negative breast cancer cells. Cancer Management and Research 10, pages 6715-6729.
Read now
Yan Chen, Qinglei Zeng, Xiufang Liu, Junliang Fu, Zhen Zeng, Zhiqin Zhao, Ze Liu, Wenlin Bai, Zheng Dong, Hongjin Liu, Xiaoxia Lu, Yunfeng Zhu & Yinying Lu. (2018) LINE-1 ORF-1p enhances the transcription factor activity of pregnenolone X receptor and promotes sorafenib resistance in hepatocellular carcinoma cells. Cancer Management and Research 10, pages 4421-4438.
Read now
Jiaqi Li, Jing Zhao, Huan Wang, Xiaohan Li, Aixia Liu, Qin Qin & Boan Li. (2018) MicroRNA-140-3p enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting pregnenolone X receptor. OncoTargets and Therapy 11, pages 5885-5894.
Read now

Articles from other publishers (8)

Maria Stefania Sinicropi, Domenico Iacopetta, Jessica Ceramella, Alessia Catalano, Annaluisa Mariconda, Michele Pellegrino, Carmela Saturnino, Pasquale Longo & Stefano Aquaro. (2022) Triclosan: A Small Molecule with Controversial Roles. Antibiotics 11:6, pages 735.
Crossref
Heloisa V. Pereira-Maróstica, Lívia Bracht, Jurandir F. Comar, Rosane M. Peralta, Adelar Bracht & Anacharis B. Sá-Nakanishi. (2022) The rapid transformation of triclosan in the liver reduces its effectiveness as inhibitor of hepatic energy metabolism. Toxicology and Applied Pharmacology 442, pages 115987.
Crossref
Junxiao Wang, Rui Liu, Yun Zhao, Zhenhu Ma, Zejie Sang, Zhenyu Wen, Xueling Yang & Hui Xie. (2021) Novel Microcrystal Formulations of Sorafenib Facilitate a Long-Acting Antitumor Effect and Relieve Treatment Side Effects as Observed With Fundus Microcirculation Imaging. Frontiers in Oncology 11.
Crossref
Min Zhang, Rongrong Zhu & Libin Zhang. (2020) Triclosan stimulates human vascular endothelial cell injury via repression of the PI3K/Akt/mTOR axis. Chemosphere 241, pages 125077.
Crossref
Huiwei Sun, Fan Feng, Hui Xie, Xiaojuan Li, Qiyu Jiang, Yantao Chai, Zhijie Wang, Ruichuang Yang, Ruisheng Li & Jun Hou. (2019) Quantitative examination of the inhibitory activation of molecular targeting agents in hepatocellular carcinoma patient‐derived cell invasion via a novel in vivo tumor model. Animal Models and Experimental Medicine 2:4, pages 259-268.
Crossref
Bin Yang, Chunping Wang, Hui Xie, Yiwu Wang, Jiagan Huang, Yihui Rong, Huixin Zhang, Huifang Kong, Yongping Yang & Yinying Lu. (2019) MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents. Cell Death & Disease 10:10.
Crossref
Du Meng, Min Meng, Anqi Luo, Xin Jing, Guanying Wang, Shangke Huang, Minna Luo, Shan Shao, Xinhan Zhao & Rui Liu. (2018) Effects of VEGFR1+ hematopoietic progenitor cells on pre-metastatic niche formation and in vivo metastasis of breast cancer cells. Journal of Cancer Research and Clinical Oncology 145:2, pages 411-427.
Crossref
Zhiyi Shao, Yibo Li, Wenjie Dai, Hui Jia, Yingshi Zhang, Qiyu Jiang, Yantao Chai, Xiaojuan Li, Huiwei Sun, Ruichuang Yang, Yu Cao, Fan Feng & Yingjie Guo. (2018) ETS-1 induces Sorafenib-resistance in hepatocellular carcinoma cells via regulating transcription factor activity of PXR. Pharmacological Research 135, pages 188-200.
Crossref